Ashwath Jayagopal - 12 Feb 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role: Chief Scientific & Dev. Ofc.
Signature: /s/ Amy Rabourn, by Power of Attorney
Issuer symbol: OCUP
Transactions as of: 12 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 14 Feb 2024, 18:35:04 UTC
Next filing: 24 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+75,000		$0.000000	75,000	12 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+225,000		$0.000000	225,000	12 Feb 2024	Common Stock	225,000	$2.66	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of February 12, 2024, subject to the Reporting Person's continuing service.
F2	The option will vest with respect to 25% on February 12, 2025, with the remaining shares vesting quarterly in 12 equal installments thereafter, subject to the Reporting Person's continuing service.